Facial reconstruction

Search LJMU Research Online

Browse Repository | Browse E-Theses

Nanocarriers Targeting Dendritic Cells for Pulmonary Vaccine Delivery

Kunda, NK, Somavarapu, S, Gordon, SB, Hutcheon, GA and Saleem, IY (2013) Nanocarriers Targeting Dendritic Cells for Pulmonary Vaccine Delivery. PHARMACEUTICAL RESEARCH, 30 (2). pp. 1-17. ISSN 0724-8741

WarningThere is a more recent version of this item available.
nitesh review 2012 proofs.pdf

Download (862kB) | Preview


Pulmonary vaccine delivery has gained significant attention as an alternate route for vaccination without the use of needles. Immunization through the pulmonary route induces both mucosal and systemic immunity, and the delivery of antigens in a dry powder state can overcome some challenges such as cold-chain and availability of medical personnel compared to traditional liquid-based vaccines. Antigens formulated as nanoparticles (NPs) reach the respiratory airways of the lungs providing greater chance of uptake by relevant immune cells. In addition, effective targeting of antigens to the most ‘professional’ antigen presenting cells (APCs), the dendritic cells (DCs) yields an enhanced immune response and the use of an adjuvant further augments the generated immune response thus requiring less antigen/dosage to achieve vaccination. This review discusses the pulmonary delivery of vaccines, methods of preparing NPs for antigen delivery and targeting, the importance of targeting DCs and different techniques involved in formulating dry powders suitable for inhalation.

Item Type: Article
Additional Information: The original publication is available at www.springer.com - see Publisher URL
Subjects: R Medicine > RM Therapeutics. Pharmacology
R Medicine > RS Pharmacy and materia medica
Divisions: Pharmacy & Biomolecular Sciences
Related URLs:
Date Deposited: 10 Sep 2014 13:27
Last Modified: 04 Sep 2021 14:49
URI: https://researchonline.ljmu.ac.uk/id/eprint/126

Available Versions of this Item

View Item View Item